145 related articles for article (PubMed ID: 6754061)
1. A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer; 1982 Dec; 50(11):2265-8. PubMed ID: 6754061
[No Abstract] [Full Text] [Related]
2. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
[TBL] [Abstract][Full Text] [Related]
4. Currently active protocols in the EORTC Breast Cancer Cooperative Group.
Mouridsen HT; Palshof T; Mattheiem W; Sylvester RJ; Rotmensz N; Paridaens RJ
Recent Results Cancer Res; 1984; 91():263-7. PubMed ID: 6374800
[No Abstract] [Full Text] [Related]
5. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
Holdaway IM
Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
[TBL] [Abstract][Full Text] [Related]
6. [Hormone therapy of patients with breast cancer].
Moiseenko VM; Semiglazov VF
Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
[No Abstract] [Full Text] [Related]
7. Aminoglutethimide in the treatment of advanced breast cancer.
Stuart-Harris RC; Smith IE
Cancer Treat Rev; 1984 Sep; 11(3):189-204. PubMed ID: 6241038
[No Abstract] [Full Text] [Related]
8. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancer.
Pronzato P; Bertelli G; Rosso M
Ann N Y Acad Sci; 1993 Nov; 698():357-61. PubMed ID: 8279775
[No Abstract] [Full Text] [Related]
10. Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
Lundgren S; Gundersen S; Klepp R; Lønning PE; Lund E; Kvinnsland S
Breast Cancer Res Treat; 1989 Nov; 14(2):201-6. PubMed ID: 2690972
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen therapy of metastatic breast cancer.
Manni A
J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
[TBL] [Abstract][Full Text] [Related]
12. Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.
Murray RM; Pitt P
Breast Cancer Res Treat; 1981; 1(2):91-5. PubMed ID: 7348572
[TBL] [Abstract][Full Text] [Related]
13. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
Brufman G; Biran S
Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
[TBL] [Abstract][Full Text] [Related]
14. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
Nadezhdina TM; Vyshinskaia GV; Lichinitser MR; Bassalyk LS; Garin AM
Vopr Onkol; 1987; 33(5):79-82. PubMed ID: 3590672
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
Brufman G
Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
Smith IE; Harris AL; Morgan M; Ford HT; Gazet JC; Harmer CL; White H; Parsons CA; Villardo A; Walsh G; McKinna JA
Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1432-4. PubMed ID: 6797571
[TBL] [Abstract][Full Text] [Related]
18. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
19. Cancer of the breast: the past decade (second of two parts).
Henderson IC; Canellos GP
N Engl J Med; 1980 Jan; 302(2):78-90. PubMed ID: 7350436
[No Abstract] [Full Text] [Related]
20. Second line hormonal therapy with aminoglutethimide in metastatic breast cancer.
Brufman G; Biran S
Acta Oncol; 1990; 29(6):717-20. PubMed ID: 2223141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
